Body mass index and breast cancer treatment-related lymphedema
Identifieur interne : 003940 ( Pmc/Corpus ); précédent : 003939; suivant : 003941Body mass index and breast cancer treatment-related lymphedema
Auteurs : Sheila H. Ridner ; Mary S. Dietrich ; Bob R. Stewart ; Jane M. ArmerSource :
- Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer [ 0941-4355 ] ; 2011.
Abstract
The main purpose was to examine longitudinally the influence of body mass index (BMI) and obesity on the development of breast cancer treatment-related lymphedema. We asked, does elevated BMI increase lymphedema risk?
A secondary analysis was conducted on de-identified data collected from 138 newly diagnosed breast cancer survivors who had arm volume measurements and symptom assessment at pre-treatment baseline and measurements up to 30 months post-surgery in a prospective longitudinal parent study. Arm volume and weight data, part of the information collected during each participant visit, were examined.
Breast cancer survivors whose BMI was ≥30 at the time of breast cancer treatment were approximately 3.6 times more likely to develop lymphedema at 6 months or greater after diagnosis than those with a BMI <30 at the time of cancer treatment (95% confidence interval, C.I., for odds ratio, O.R., 1.42–9.04,
Pre-treatment BMI may be a risk factor for lymphedema. Weight gain post-treatment may not be. Further research is warranted.
Url:
DOI: 10.1007/s00520-011-1089-9
PubMed: 21240649
PubMed Central: 4480912
Links to Exploration step
PMC:4480912Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Body mass index and breast cancer treatment-related lymphedema</title>
<author><name sortKey="Ridner, Sheila H" sort="Ridner, Sheila H" uniqKey="Ridner S" first="Sheila H." last="Ridner">Sheila H. Ridner</name>
</author>
<author><name sortKey="Dietrich, Mary S" sort="Dietrich, Mary S" uniqKey="Dietrich M" first="Mary S." last="Dietrich">Mary S. Dietrich</name>
</author>
<author><name sortKey="Stewart, Bob R" sort="Stewart, Bob R" uniqKey="Stewart B" first="Bob R." last="Stewart">Bob R. Stewart</name>
</author>
<author><name sortKey="Armer, Jane M" sort="Armer, Jane M" uniqKey="Armer J" first="Jane M." last="Armer">Jane M. Armer</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PMC</idno>
<idno type="pmid">21240649</idno>
<idno type="pmc">4480912</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4480912</idno>
<idno type="RBID">PMC:4480912</idno>
<idno type="doi">10.1007/s00520-011-1089-9</idno>
<date when="2011">2011</date>
<idno type="wicri:Area/Pmc/Corpus">003940</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">003940</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Body mass index and breast cancer treatment-related lymphedema</title>
<author><name sortKey="Ridner, Sheila H" sort="Ridner, Sheila H" uniqKey="Ridner S" first="Sheila H." last="Ridner">Sheila H. Ridner</name>
</author>
<author><name sortKey="Dietrich, Mary S" sort="Dietrich, Mary S" uniqKey="Dietrich M" first="Mary S." last="Dietrich">Mary S. Dietrich</name>
</author>
<author><name sortKey="Stewart, Bob R" sort="Stewart, Bob R" uniqKey="Stewart B" first="Bob R." last="Stewart">Bob R. Stewart</name>
</author>
<author><name sortKey="Armer, Jane M" sort="Armer, Jane M" uniqKey="Armer J" first="Jane M." last="Armer">Jane M. Armer</name>
</author>
</analytic>
<series><title level="j">Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer</title>
<idno type="ISSN">0941-4355</idno>
<idno type="eISSN">1433-7339</idno>
<imprint><date when="2011">2011</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en"><sec id="S1"><title>Purpose</title>
<p id="P1">The main purpose was to examine longitudinally the influence of body mass index (BMI) and obesity on the development of breast cancer treatment-related lymphedema. We asked, does elevated BMI increase lymphedema risk?</p>
</sec>
<sec id="S2"><title>Methods</title>
<p id="P2">A secondary analysis was conducted on de-identified data collected from 138 newly diagnosed breast cancer survivors who had arm volume measurements and symptom assessment at pre-treatment baseline and measurements up to 30 months post-surgery in a prospective longitudinal parent study. Arm volume and weight data, part of the information collected during each participant visit, were examined.</p>
</sec>
<sec id="S3"><title>Results</title>
<p id="P3">Breast cancer survivors whose BMI was ≥30 at the time of breast cancer treatment were approximately 3.6 times more likely to develop lymphedema at 6 months or greater after diagnosis than those with a BMI <30 at the time of cancer treatment (95% confidence interval, C.I., for odds ratio, O.R., 1.42–9.04, <italic>p</italic>
=0.007). Those with a general BMI increase or a BMI rise to 30 or greater during their first 30 months of survivorship were not more likely to develop late-onset lymphedema than those who did not have similar changes in BMI.</p>
</sec>
<sec id="S4"><title>Conclusions</title>
<p id="P4">Pre-treatment BMI may be a risk factor for lymphedema. Weight gain post-treatment may not be. Further research is warranted.</p>
</sec>
</div>
</front>
</TEI>
<pmc article-type="research-article"><pmc-comment>The publisher of this article does not allow downloading of the full text in XML form.</pmc-comment>
<pmc-dir>properties manuscript</pmc-dir>
<front><journal-meta><journal-id journal-id-type="nlm-journal-id">9302957</journal-id>
<journal-id journal-id-type="pubmed-jr-id">8479</journal-id>
<journal-id journal-id-type="nlm-ta">Support Care Cancer</journal-id>
<journal-id journal-id-type="iso-abbrev">Support Care Cancer</journal-id>
<journal-title-group><journal-title>Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer</journal-title>
</journal-title-group>
<issn pub-type="ppub">0941-4355</issn>
<issn pub-type="epub">1433-7339</issn>
</journal-meta>
<article-meta><article-id pub-id-type="pmid">21240649</article-id>
<article-id pub-id-type="pmc">4480912</article-id>
<article-id pub-id-type="doi">10.1007/s00520-011-1089-9</article-id>
<article-id pub-id-type="manuscript">NIHMS695899</article-id>
<article-categories><subj-group subj-group-type="heading"><subject>Article</subject>
</subj-group>
</article-categories>
<title-group><article-title>Body mass index and breast cancer treatment-related lymphedema</article-title>
</title-group>
<contrib-group><contrib contrib-type="author"><name><surname>Ridner</surname>
<given-names>Sheila H.</given-names>
</name>
<degrees>PhD, RN, FAAN</degrees>
<xref rid="FN2" ref-type="author-notes">1</xref>
<aff id="A1">Vanderbilt University School of Nursing</aff>
</contrib>
<contrib contrib-type="author"><name><surname>Dietrich</surname>
<given-names>Mary S.</given-names>
</name>
<degrees>PhD</degrees>
<xref rid="FN2" ref-type="author-notes">1</xref>
<xref rid="FN3" ref-type="author-notes">2</xref>
<aff id="A2">Vanderbilt University School of Nursing</aff>
</contrib>
<contrib contrib-type="author"><name><surname>Stewart</surname>
<given-names>Bob R.</given-names>
</name>
<degrees>EdD</degrees>
<xref rid="FN4" ref-type="author-notes">3</xref>
<aff id="A3">University of Missouri Sinclair School of Nursing</aff>
</contrib>
<contrib contrib-type="author"><name><surname>Armer</surname>
<given-names>Jane M.</given-names>
</name>
<degrees>PhD, RN, FAAN</degrees>
<xref rid="FN4" ref-type="author-notes">3</xref>
<aff id="A4">University of Missouri Sinclair School of Nursing</aff>
</contrib>
</contrib-group>
<author-notes><corresp id="FN1">Corresponding Author: 460 21<sup>st</sup>
Avenue South, 525 Godchaux Hall, Nashville, TN 37240 USA, Phone: 615-322-0831, Fax: 615-343-7788, <email>sheila.ridner@vanderbilt.edu</email>
</corresp>
<fn id="FN2"><label>1</label>
<p>Vanderbilt University School of Nursing</p>
</fn>
<fn id="FN3"><label>2</label>
<p>Vanderbilt University School of Nursing, Vanderbilt University School of Medicine, Department of Biostatistics, 460 21<sup>st</sup>
Avenue South, 410 Godchaux Hall, Nashville, TN 37240 USA</p>
</fn>
<fn id="FN4"><label>3</label>
<p>University of Missouri Sinclair School of Nursing, Ellis Fischel Cancer Center, DC 116.05 Suite 408 EFCC, University of Missouri, Columbia, MO 65211 USA</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted"><day>4</day>
<month>6</month>
<year>2015</year>
</pub-date>
<pub-date pub-type="epub"><day>16</day>
<month>1</month>
<year>2011</year>
</pub-date>
<pub-date pub-type="ppub"><month>6</month>
<year>2011</year>
</pub-date>
<pub-date pub-type="pmc-release"><day>25</day>
<month>6</month>
<year>2015</year>
</pub-date>
<volume>19</volume>
<issue>6</issue>
<fpage>853</fpage>
<lpage>857</lpage>
<pmc-comment>elocation-id from pubmed: 10.1007/s00520-011-1089-9</pmc-comment>
<abstract><sec id="S1"><title>Purpose</title>
<p id="P1">The main purpose was to examine longitudinally the influence of body mass index (BMI) and obesity on the development of breast cancer treatment-related lymphedema. We asked, does elevated BMI increase lymphedema risk?</p>
</sec>
<sec id="S2"><title>Methods</title>
<p id="P2">A secondary analysis was conducted on de-identified data collected from 138 newly diagnosed breast cancer survivors who had arm volume measurements and symptom assessment at pre-treatment baseline and measurements up to 30 months post-surgery in a prospective longitudinal parent study. Arm volume and weight data, part of the information collected during each participant visit, were examined.</p>
</sec>
<sec id="S3"><title>Results</title>
<p id="P3">Breast cancer survivors whose BMI was ≥30 at the time of breast cancer treatment were approximately 3.6 times more likely to develop lymphedema at 6 months or greater after diagnosis than those with a BMI <30 at the time of cancer treatment (95% confidence interval, C.I., for odds ratio, O.R., 1.42–9.04, <italic>p</italic>
=0.007). Those with a general BMI increase or a BMI rise to 30 or greater during their first 30 months of survivorship were not more likely to develop late-onset lymphedema than those who did not have similar changes in BMI.</p>
</sec>
<sec id="S4"><title>Conclusions</title>
<p id="P4">Pre-treatment BMI may be a risk factor for lymphedema. Weight gain post-treatment may not be. Further research is warranted.</p>
</sec>
</abstract>
<kwd-group><kwd>Body mass index</kwd>
<kwd>Breast cancer</kwd>
<kwd>Lymphedema</kwd>
</kwd-group>
</article-meta>
</front>
</pmc>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Pmc/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003940 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd -nk 003940 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= LymphedemaV1 |flux= Pmc |étape= Corpus |type= RBID |clé= PMC:4480912 |texte= Body mass index and breast cancer treatment-related lymphedema }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/RBID.i -Sk "pubmed:21240649" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd \ | NlmPubMed2Wicri -a LymphedemaV1
This area was generated with Dilib version V0.6.31. |